Cardiology Division, Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Am J Ther. 2010 Nov-Dec;17(6):e208-20. doi: 10.1097/MJT.0b013e3181bdc65d.
The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation. The American College of Cardiology/American Heart Association class I, IIa, and III indications for an AICD are discussed. Patients with AICDs should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing at a rate of 70/minute. Patients with AICDs should be treated with beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
自动植入式心脏复律除颤器（AICD）是治疗危及生命的室性心动过速或心室颤动患者的最有效方法。本文讨论了美国心脏病学会/美国心脏协会 I 类、IIa 类和 III 类 AICD 适应证。AICD 患者应接受双心室起搏治疗，而不是以 70 次/分钟的速率进行双腔频率适应性起搏治疗。AICD 患者应接受β受体阻滞剂、他汀类药物、血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂治疗。
